Is bioMérieux S.A. (BMXMF) a Buy, Sell, or Hold?
OTC : BMXMF
bioMérieux S.A. — News
$80.31 USD
-$0.35 (-0.43%)
- Volume
- 66
- Average Volume
- 231
- Market Capitalization
- $9.48B
- P/E Ratio
- 20.89
- Dividend Yield
- 1.39%
- Price Target
- Year High
- $152.00
- Year Low
- $77.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.27
- Current Ratio
- $2.39
| Source | Headline |
|---|---|
|
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript seekingalpha.com - 2026-04-23 11:31:35 |
|
Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF)
HealthEquity (NASDAQ: HQY - Get Free Report) and bioMerieux (OTCMKTS:BMXMF - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Institutional and Insider Ownership 99.6% of HealthEquity shares are held defenseworld.net - 2026-04-21 03:21:02 |
